How Should Young People Learn About Drugs?

Harm reduction may be the answer, but D.A.R.E. programs are still active in 75 % of U.S. school districts and in more than 43 countries.

Oregon’s Psychedelic Data Would Benefit Legalization – If Done Right

Data is essential for the expansion of services, but it must be implemented in a way that protects both client and facilitators.

Are You Experienced?

It behooves anyone who intends to work as a psychedelic guide to have psychedelic experience; you’re either on the bus or you’re not.

Digital Therapeutics and Psychedelic Medicines are Evolving Together

In this interview, Firefly VR founder Shel Mann discusses how immersive technology can help prepare patients for psychedelic therapies, and the integration of virtual tools into mainstream healthcare.

To Trip or Not to Trip? Why Non-Hallucinogenic Treatments Must Be Part of the Solution

The therapeutic benefits of psychedelic medicines may not require the psychoactive effects.

COMP360 Psilocybin Therapy Shows Promise in Bipolar Disorder

The early results of a COMPASS Pathways clinical trial quell some concerns related to the safety of psychedelic therapy for individuals with bipolar disorder.

Ram Dass Was “Only Jewish on My Parents’ Side”

The author recalls conversations with the spiritual leader and psychedelic pioneer about his Jewish roots.

The Myth of the Psychedelic Santa

Be the nerdiest person at your holiday parties this year by dispelling one of the most persistent psychedelic history myths!

Is the High Cost of Psychedelic Therapy Worth It?

As psychedelic-assisted therapies near FDA approval, questions remain about cost, who’s paying, and how much it saves patients and insurers in the long run.

How Many Likes Does It Take to be a Psychedelic Thought Leader?

In an era where thought leaders are minted by social media metrics, some influencers may be one viral video away from being tomorrow’s psychedelic luminaries.